How Semaglutide May Change the Obesogenic Environment

Semaglutide, initially used for type 2 diabetes, shows potential in addressing obesity. In this video, filmed at the Healthy food Guide Pro Nutrition LIVE 2024 seminar, Jane Martin discusses its appetite-regulating effects and societal impact, emphasising reshaping eating habits.
Jane Martin
Date:
10 February 2025
Duration:
19:16
Register now to watch this on demand or login if you already have an account.

Jane Martin leads the Food for Health Alliance, a partnership involving Cancer Council Victoria, VicHealth, and Deakin University. With over 30 years in public health advocacy, she focuses on improving diets and preventing obesity in Australia. Recognised for her contributions, Jane advises governments, collaborates on research, and holds leadership roles in key health organisations.

This content is available for Healthy Food Guide Pro members only.

Don't worry, registration is free!

Click here to register or login if you already have an account.

More Webinars